where in the hypertension care continuum patients are lost to care is sparse. This information, however, is essential for effective targeting of interventions by health services and monitoring progress in improving hypertension care. We aimed to determine the cascade of hypertension care in 44 LMICs-and its variation between countries and population groups-by dividing the progression in the care process, from need of care to successful treatment, into discrete stages and measuring the losses at each stage.
Introduction
Hypertension is a major risk factor for several common non-communicable diseases (NCDs), particularly stroke, heart disease, and chronic kidney disease. 1 The prevalence of hypertension is increasing rapidly in lowincome and middle-income countries (LMICs). 2 The regions with the highest prevalence of hypertension are thought to be sub-Saharan Africa, south Asia, and central and eastern Europe, all regions largely comprised of LMICs. 2 Evidence regarding where in the hypertension care continuum patients stop progressing and how these patterns vary between and within countries, is essential to designing effective interventions to improve hypertension control. Addi tionally, assessing the success of health systems in managing important-yet inexpensively treatable-NCD risk factors, such as hypertension, 3 would be a useful measure of health system performance that could be tracked as part of national and international targets, such as universal health coverage. 4 Specifically, as LMICs undergo the epidemiological transition, such a measure of health system performance could help track countries' progress in shifting health services away from mainly providing episodic care for acute communicable conditions towards furnishing long-term, person-centred care for chronic non-communicable conditions. Estimates of health system performance regarding hypertension from nationally representative studies in LMICs are sparse. 5 This dearth of evidence, along with the projected rapid rise in the number of people with hypertension in these settings, 6 is the main reason for our focus on LMICs, rather than high-income countries. To inform the design of interventions in health services and to provide a cross-country comparison of health system performance for managing hypertension, we aimed to determine where patients in LMICs are lost to care along the hypertension management con tinuum and how these patterns vary among countries and population groups within these countries.
Methods

Data sources
In this cross-sectional study, we requested access to the most recent nationally representative WHO Stepwise Approach to Surveillance (STEPS) survey done since 2005, for all countries that were defined by the World Bank as a LMIC at the time of the survey. 7 We selected STEPS surveys because they use the same standardised questionnaire, sample a wide age range of adults, and are the official approach developed by WHO for monitoring NCD risk factors at the population level. 8 If an eligible STEPS dataset was not available for a LMIC, or we could not gain access to it, we conducted a systematic search with Google, to identify the most recent nationally representative household survey from the LMIC that was conducted in 2005 or later, collected data on at least three 10-year age groups older than 15 years, measured blood pressure in participants twice or more, and asked
Research in context
Evidence before this study We searched MEDLINE for work published between Jan 1, 1966, and Jan 31, 2019, with variations of the search terms "hypertension", "screened", "aware", "treated", and "controlled" in the title or abstract. To date, the largest study of individual-level data to compare hypertension awareness, treatment, and control between low-income and middle-income countries (LMICs) was the Prospective Urban Rural Epidemiology (PURE) study. The PURE study also examined how the hypertension care cascade varied among population groups within countries. However, this study was based on a convenience sample rather than a random sample of communities, used data from 2003 to 2009, and only included 14 LMICs.
Added value of this study
To our knowledge, this is the largest study to date that analyses individual-level data from nationally representative samples of adults in LMICs to determine at which stages in the hypertension care process patients are lost, and how these losses vary between and within countries. We make four key additions to the current evidence base. First, for each of 44 LMICs, we quantified the loss of individuals with hypertension at each step of the hypertension care cascade; these data can be used to guide national policy makers in deciding whether to prioritise efforts to improve screening, diagnosis, initiation of treatment, or medication adherence and care retention. Second, we examined how the hypertension care cascade varies between different population groups within LMICs, providing important information on possible target groups for relevant interventions. Third, by benchmarking countries' performance against their gross domestic product per capita, our analysis identifies countries that performed better than expected based on their wealth and thus likely hold valuable policy lessons for countries at a similar level of economic development. Finally, our study provides a benchmark of health system performance for managing hypertension in LMICs against which future progress can be compared.
Implications of all the available evidence
Although the proportion of adults who achieved control of their hypertension was low in all four world regions that we examined, countries in Latin America and the Caribbean showed, on average, the best care cascade performance, whereas countries in sub-Saharan Africa tended to show the poorest performance. Well designed and well targeted interventions to improve hypertension care in LMICs are urgently needed. More research is required to understand why some LMICs achieve substantially better hypertension care cascade indicators than others and how the hypertension care cascade can be improved most effectively in different settings. questions on at least two steps in the hypertension care cascade.
This study was designated "not human subjects research" and was thus deemed not to require additional ethical approval by the institutional review board of the Harvard T H Chan School of Public Health on May 9, 2018.
Definitions of hypertension and the cascade of care
Hypertension was defined as systolic blood pressure of at least 140 mm Hg or diastolic blood pressure of at least 90 mm Hg or reported use of medication for hypertension. For participants with three blood pressure measure ments, we used the mean of the last two measurements; for participants with only two measurements, we computed the mean of both available measurements.
We calculated the proportion of all those with hypertension who had ever received a blood pressure measurement (designated ever measured), had been diagnosed with hypertension by a health-care provider (designated diagnosed), were currently taking antihypertensive medication (designated treated), and had been treated (or had received relevant lifestyle advice) and had a systolic blood pressure of less than 140 mm Hg and a diastolic blood pressure of less than 90 mm Hg (designated controlled). In additional analyses, we also evaluated these proportions when defining treated as having received relevant lifestyle advice or taking antihypertensive medication (appendix). Further details on the computation of the care cascade are shown in the appendix.
Statistical analysis
None of the analyses were prespecified. Countries were categorised according to the regional groupings of the WHO regional offices; however, the European and eastern Mediterranean regions and the southeast Asia and western Pacific regions were merged to avoid only having two countries with data in a region. All analyses accounted for the multi-stage cluster random sampling of the surveys by use of sampling weights. In our primary analyses, we weighted each country relative to its population size in 2015, when computing the hypertension care cascade at the global and regional level. 9 We also did additional analyses that assigned the same weight to each country (appendix).
We plotted the proportion of participants with hypertension who reached each step of the care cascade in each country against the country's gross domestic product (GDP) per capita (in constant 2011 international dollars, as estimated by the World Bank) 10 in the year of survey data collection, to ascertain health system performance relative to a country's wealth. For each cascade step, we also regressed the proportion of participants with hypertension who reached the given step on sex, 10-year age group, education, household wealth quintile, body-mass index (BMI) group (in which a BMI <18·5 kg/m² was defined as underweight; a BMI of ≥18·5 kg/m² but <25·0 kg/m² was defined as a healthy weight; a BMI of ≥25·0 kg/m² but <30·0 kg/m² was defined as over weight; and a BMI of ≥30·0 kg/m² was defined as obese), and a binary indicator for current tobacco smoking. Specifically, we fitted univariable and multivariable Poisson regressions with country-level fixed effects, adjusting standard errors for clustering at the level of the primary sampling unit. In 20 countries, household wealth quintiles were calculated based on a principal component analysis of participants' answers to several questions on key household dwelling characteristics and household owner ship of durable goods (ie, goods that are not completely consumed in one use). In 14 countries these questions were not asked, but we did have data on household income in these countries, which we used instead to approximate household wealth quintiles in these surveys. More detail on the computation of the household wealth quintiles is shown in the appendix. Household wealth data were not available for ten countries, smoking data were not available for six countries, and BMI data were not available for five countries (appendix). These countries were therefore removed from the regressions that included these as independent variables. All analyses were complete case analyses.
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to the data and had final responsibility for the decision to submit for publication.
Results
We attained individual-level STEPS survey data from 22 LMICs and, from our systematic search, we included survey datasets from an additional 22 LMICs (appendix). 40 countries measured blood pressure with a digital upper arm meter, two countries with a digital wrist meter, and two countries with a manual mercury sphygmomanometer (appendix). 35 countries measured blood pressure three times, five countries twice, and one country (the Seychelles) five times. Three countries measured blood pressure twice, with a third mea surement if the first two measurements differed by more than a predefined margin (appendix). We performed our analyses on these survey data between May 12, 2018, and March 5, 2019.
The survey-level median response rate was 90·9% (IQR 81·5-95·6; table 1). Among those interviewed, the proportion of participants with a missing outcome (blood pressure or questionnaire response to whether the participant has ever had their blood pressure measured) ranged from 0% in Belize, Romania, and the Seychelles to 30·2% in Mexico, and the survey-level median proportion of participants with missing outcome data was 2·3% (0·6-8·6). 1 100 507 participants with outcome data were included in the analysis. The survey-level median age among these participants was The prevalence of hypertension and undiagnosed hyper tension by country and 10-year age group is shown in the appendix. Using sampling weights that weighted countries in proportion to their population size, we estimated that, among those with hypertension, 73·6% of participants (95% CI 72·9-74·3) had ever had their blood pressure measured, 39·2% of participants (38·2-40·3) had been diagnosed with hypertension before the survey, 29·9% of participants (28·6-31·3) had been treated, and 10·3% of participants (9·6-11·0) had achieved control of their hypertension.
Of the four world regions examined, Latin America and the Caribbean had the highest proportion of individuals reaching each stage of the care cascade, whereas sub-Saharan Africa had the lowest (figure 1; appendix). Fewer than 5% of those with hypertension had achieved control of their condition in ten (63%) of 16 countries in sub-Saharan Africa, versus three (38%) of eight countries in southeast Asia and the western Pacific, one (10%) of ten countries in Europe and the eastern Mediterranean, and none (0%) of the ten countries in Latin America and the Caribbean (appendix). Within regions, there was substantial variation among countries in the proportion of individuals with hypertension attaining each cascade step. Costa Rica was the best-performing country regarding the propor tion of people reaching each cascade step in Latin America and the Caribbean (figure 1). Other highperforming countries, relative to other countries in their region, were Bangladesh, Namibia, and Romania.
GDP per capita was positively associated with a country's performance for each cascade step (figure 2). Countries that performed substantially better on all measured cascade steps than predicted based on their GDP per capita in the year of the survey were Bangladesh, Brazil, Costa Rica, Ecuador, Kyrgyzstan, and Peru. Countries that performed significantly worse on all measured cascade steps than expected based on their GDP per capita were Albania, Indonesia, Tanzania, Uganda, and South Africa.
Those who were female, older, did not currently smoke, and who were in higher quintiles for household wealth were more likely to reach each step of the cascade in both univariable and multivariable regressions (table 2) . Additionally, being overweight or obese was associated with a higher probability of reaching each cascade step in all regressions except for the last step, from treatment to control of blood pressure. Furthermore, we found that educational attainment was positively associated with reaching each cascade step in the multivariable regressions, 29 The population estimate for Zanzibar was taken from the Tanzania Population Projection Report 2013-35. 30 GDP=gross domestic product. NA=not applicable. *Total across all countries. †Percentage is the survey-level median. and people who were obese had a higher probability of reaching each cascade step than people who were overweight (with the exception of the last cascade step in the multivariable regression). The positive associ ations between attainment of each cascade step and education were strongest in low-income countries and weakest in upper middle-income countries (appendix). By region, the associations with education were strongly positive in sub-Saharan Africa and did not exist, or they were negative in the Europe and eastern Mediterranean region. A stratification of the proportion of participants with hypertension who reached each cascade step by sex, age group, and education demonstrated that the proportion achieving control was less than 20% in all age and education group combinations; in each educational attainment category, less than half of individuals were diagnosed in age groups younger than 55 years; and women had a higher probability of reaching each cascade step than men in almost all age and education group combinations ( figure 3) .
The care cascade disaggregated by 10-year age group and the hypertension care cascade for each country are shown in the appendix. The relative differences between regions and countries regarding the proportion of people reaching each cascade step were similar to the primary results when defining treatment as receiving lifestyle advice or taking antihypertensive medication, when weighting countries equally, and when disaggregating the care cascade in each region by 10-year age group. Performance relative to GDP per capita-based estimates were also similar to the primary 
Discussion
Overall, the performance of health systems in LMICs regarding the management of hypertension was poor: less than half of those with hypertension were diagnosed, less 
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Secondary education or further
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Body-mass index group
Tobacco smoking Not currently smoking
Multivariable regression with age group, sex, and education †
Sex
Male
Age, years Within countries, we found that men were less likely to reach each step of the hypertension care cascade than women, which could be due to several factors, such as a focus of primary health-care services on maternal and child health, gender norms concerning care-seeking, and health-care facility opening hours. As hypertension care services are strengthened in LMICs, it will be crucial that health systems identify ways of engaging men in hypertension screening and care to avoid further widening the existing gender gap in life expectancy. 11 Additionally, given our finding that those who were smokers and who were overweight or obese generally did not have a higher probability of completing the hypertension cascade (ie, to control of their hypertension), it will be important for hypertension services in LMICs to more consistently reach and retain those at the highest risk of cardiovascular disease. Finally, we observed that individuals with lower education and household wealth were generally more likely to be lost to care before reaching the final cascade stage of blood pressure control. This finding is especially concerning given that those of a lower socioeconomic 
Multivariable regressions with all predictor variables ‡
Sex
Body-mass index group RRs are shown with 95% CIs, which are adjusted for clustering at the level of the primary sampling unit. Schooling categories are defined as having attended (but not necessarily completed) the indicated level of education. RR=risk ratio. *Included only one of the variables shown in the table and a binary indicator for each country (country-level fixed effects). †Included sex, age group, education, and a binary indicator for each country (country-level fixed effects). ‡Included sex, age group, education, household wealth quintile, body-mass index, tobacco smoking, and a binary indicator for each country (country-level fixed effects). status are likely less able to access high-quality care for cardiovascular disease events (such as heart attacks and strokes) and are more likely to have catastrophic healthcare expenditures from use of the health care to which they do have access. 12 More optimistically, however, our findings also imply that well designed investments in improving hypertension care present an opportunity to reduce health inequalities between socioeconomic groups in LMICs. Relative to their GDP per capita, Costa Rica, Kyrgyzstan, and Bangladesh performed well in our analysis of cascade step attainment, implying that important lessons could be learned by studying the health policies and systems of these countries. We briefly outline three possible reasons that could partially explain the comparatively strong perfor mance of these countries. First, these countries all have established primary health-care system structures at the local level. Costa Rica's Equipos Básicos de Atención Integral en Salud clinics each serve a population of about 4000 people and offer a full range of primary care and health promotion services. 13 Similarly, Kyrgyzstan has estab lished family group practices that provide comprehensive primary health care, with each practice serving a village of at least 2000 inhabitants. 14 Since 2009, Bangladesh has invested in the establishment of approximately 14 000 community clinics, which are tasked with providing screening for hypertension and diabetes. Bangladesh also has an extensive number of informal providers, licensed and unlicensed drug stores, and nongovernmental organisations throughout the country, 15 which are likely to fulfil an important role in meeting the population's demand for NCD care at the local level. Second, the health systems of Costa Rica and Kyrgyzstan have implemented structures that allow for effective community outreach for NCDs. Each of Costa Rica's community clinics include at least one community health worker who measures blood pressure during home visits and follows up at the homes of patients lost to care. 16, 17 Community health workers in Costa Rica also hold health promotion sessions in community settings, including on prevention of cardiovascular disease; these sessions likely help to generate demand for hypertension screening and care. Kyrgyzstan has estab lished village health committees, which consist of volunteers who were trained by primary health-care staff to provide basic health promotion and care services, including for hypertension. 14 Although Bangladesh has several large-scale community health worker programmes, these mostly do not yet focus on NCDs. 18 However, moving forward, the existence of functional and substantial community health worker programmes presents an important opportunity for the For more on Community-based health care by the Bangladesh Government see www. community.clinic.gov.bd country to further improve hypertension and NCD care. Finally, antihypertensive medications are generally both available and affordable in all three countries, which is not the norm in many LMICs. 19 In Costa Rica, these medications are fully covered under the Costa Rican social security fund, and they are widely available at primary care facilities. 17 In Kyrgyzstan, a 2015 survey 20 found that key antihypertensive medications were widely available and generally affordable to the local population. Similarly, in Bangladesh, the PURE study 21 found that, of 55 communities, calcium-channel blockers were available in 43 communities and ß blockers were available in 49 communities, and only 7% of sampled households were unable to afford at least one type of antihypertensive medication.
Although the hypertension care cascade is a useful measure of health system performance in LMICs, there are important contextual factors beyond the health system that likely are responsible for some of the differences in the success of hypertension management that we observed between and within countries. As we show, the probability of reaching each of the care cascade steps likely is affected by individuals' economic circumstances which, in turn, vary widely between and within countries. For instance, even if care is provided free of charge, time lost from income-generating activities and transport costs can still pose a substantial obstacle to accessing care for those with little income and savings. 22 Likewise, individuals with lower edu cational attainment might be less well equipped to engage with relevant health promotion messages and to actively negotiate an effective treatment plan with health-care providers. In addition to these socioeconomic circumstances, epidemiological factors could affect the hyper tension care cascade. For instance, adults living in populations that are exposed to a high risk of a fatal non-cardiovascular disease event, such as through infectious diseases, might be less willing to invest time, effort, and money into the prevention of a heart attack or stroke. Similarly, although hypertension control can be achieved solely through medications, social and environmental factors that affect blood pressuresuch as sodium content of diets, 23 air pollution, 24 conduciveness of the physical environment to physical activity, 23 and social norms regarding diet, excess weight, and exercise-likely also have an effect on the probability that indi viduals achieve hypertension control, especially among adults with low medication adherence.
Our study of nationally representative surveys has several limitations. First and foremost, although many surveys used the same WHO STEPS questionnaire to elicit information about hypertension care and employed a similar approach to measuring blood pressure, there were some differences in how questions were phrased and translated into the local languages, and in how blood pressure was measured. These disparities might have affected our estimates and thus be responsible for some of the variation that we observed between countries and regions. Of note, however, is that the core elements of the questions asked about hypertension care were the same across surveys. Second, the age range sampled in each survey varied between countries. We have addressed this issue by controlling for age group in our multivariable regressions, and by providing figures showing the regional hypertension care cascades and the relationships between cascade attainment and GDP per capita separately for each 10-year age group (appendix). Third, although, to our knowledge, our study includes the largest set of LMICs of any study on this topic thus far, the 44 LMICs in this analysis (representing 67% of the population living in LMICs worldwide) 9 are not representative of all LMICs globally. Specifically, it is possible that LMICs included in this analysis had better hypertension care indicators because implementing a survey that was eligible for this study could be a sign of a country's commitment to hypertension care. Fourth, the surveys were done in different years. Each country's performance should thus be interpreted as the performance in the given survey year rather than as the country's current performance. To reduce bias from secular trends when com paring countries against each other, we benchmarked performance against each country's GDP per capita in the survey year (rather than current GDP per capita). Fifth, even though the survey-level median proportion of missing values regarding the variables needed to ascertain the hypertension care cascade was only 2·3%, some countries had a substantially higher proportion of participants with missing outcome data, which could have resulted in selection biases. Sixth, because of data constraints, we used the same threshold in each survey to define a blood pressure that requires treatment. This approach, thus, ignored that guidelines in use in some countries at the time of the survey may have defined eligibility for antihypertensive medications differently, such as based on a cardiovascular disease risk score or target organ damage. Finally, because we did not include a previous hypertension diagnosis in our definition of hypertension, we might have falsely excluded some participants with hypertension from our care cascade analysis. Our hypertension definition, however, is the same as that used in other studies [25] [26] [27] [28] of hypertension care. Moreover, our definition yields conservative estimates for the loss of individuals with hypertension along the care cascade, under the assumption that some of those who reported a previous hypertension diagnosis but had a normal blood pressure and did not report to be on treatment, did, in fact, not have hypertension.
We have identified notable variation in the hypertension care cascade between and within countries, which can guide government decisions regarding future health policies and the design of appropriate interventions, such as who to target and whether to prioritise efforts to improve screening, diagnosis, treatment initiation, or medication adherence. Given that hypertension is a major risk factor for several of the most common causes of death in LMICs, 1 and that the condition can be effectively controlled at a low cost, 3 monitoring the development of the hypertension care cascade over time would likely be a worthwhile investment, providing feedback on the effectiveness of policy and health system reforms that are aimed at addressing unmet needs for hypertension care in LMICs. The magnitude of the losses in the hypertension care cascade, which we have measured in this study, indicates that reducing the burden of hypertension through health system improvements will be a formidable undertaking requiring strong political will and financial commitments.
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